WILMINGTON, DE, FIZE Medical, a leader in fluid management optimization, is excited to announce the successful closure of its $30 million Series A funding round.
FIZE Medical is excited to announce the successful closure of its $30 million Series A funding round, including a $14 million Series A-4 round led by Rapha Capital Management and its managed fund, Rapha Capital PE Life Sciences Fund VI. Additional investors included Valitas Venture Capital and eHealth Ventures.
FIZE-kUO® strives to empower clinicians with real-time, actionable data at their fingertips, enabling next-generation, AI-powered fluid management. The company consistently pushes the boundaries of fluid management technology, revolutionizing patient care and improving medical efficiencies worldwide.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
